MISSY EDWARDS STRATEGIES, LLC for GENENTECH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 959, "Pharmaceutical Compounding Quality and Accounting Act" H.R. 1416, "Cancer Patient Protection Act of 2013" S. 957, "Drug Supply Chain Security" H.R. 1919, " Safeguarding America's Pharmaceuticals Act"
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA M EDWARDS | Legislative Assistant to Senator Thad Cochran |
Taxation/Internal Revenue Code TAX
General tax issues and tax extenders (R&D tax credit) and tax treatment of foreign-owned U.S. corporations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA M EDWARDS New | Legislative Assistant to Senator Thad Cochran |
Budget/Appropriations BUD
Following issues related to the budget and appropriations process FY13 appropriations for FDA as well as the potential outcomes for negotiations on altering sequestration targets via legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA M EDWARDS | Legislative Assistant to Senator Thad Cochran |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| F. HOFFMANN-LA ROCHE LTD. | Switzerland | Switzerland | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.